Rimegepant

Chemical formula: C₂₈H₂₈F₂N₆O₃  Molecular mass: 534.568 g/mol  PubChem compound: 51049968

Therapeutic indications

Rimegepant is indicated for:

Migraine with or without aura

Population group: only adults (18 years old or older)

at least one of
Migraine with aura
Migraine without aura

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Episodic migraine

Population group: only adults (18 years old or older)

Rimegepant is indicated for the preventive treatment of episodic migraine in adults who have at least 4 migraine attacks per month.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2020: NURTEC ODT Orally disintegrating tablet
Summary of Product Characteristics (SPC) 2022: VYDURA Oral lyophilisate
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈